Be Familiar With Baxdrostat for Resistant Hypertension
Patients may come in on new Rx baxdrostat (Baxfendy), the first aldosterone synthase inhibitor for uncontrolled or resistant hypertension.
It prevents aldosterone from being made...which helps to reduce sodium and water retention. This is different from mineralocorticoid receptor antagonists (spironolactone, etc)...which block aldosterone from binding to its receptors after it’s produced.
Evidence suggests that adding once daily baxdrostat lowers systolic blood pressure by about 10 mm Hg more than placebo over 12 weeks...in patients with hypertension not controlled on multiple BP meds.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote